Phase 3 women-only HIV study sheds light on safe and effective antiretroviral treatments
Monday, September 21, 2015 - 14:00
in Health & Medicine
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens.